|
|
|
|
| LEADER |
01000naa a22002652 4500 |
| 001 |
NLM256700699 |
| 003 |
DE-627 |
| 005 |
20231224181224.0 |
| 007 |
cr uuu---uuuuu |
| 008 |
231224s2016 xx |||||o 00| ||eng c |
| 024 |
7 |
|
|a 10.1016/j.clim.2016.01.006
|2 doi
|
| 028 |
5 |
2 |
|a pubmed24n0855.xml
|
| 035 |
|
|
|a (DE-627)NLM256700699
|
| 035 |
|
|
|a (NLM)26794912
|
| 035 |
|
|
|a (PII)S1521-6616(16)30007-9
|
| 040 |
|
|
|a DE-627
|b ger
|c DE-627
|e rakwb
|
| 041 |
|
|
|a eng
|
| 100 |
1 |
|
|a Yang, Lin
|e verfasserin
|4 aut
|
| 245 |
1 |
0 |
|a Mimotope mimicking epidermal growth factor receptor alleviates mononuclear cell infiltration in exocrine glands induced by muscarinic acetylcholine 3 receptor
|
| 264 |
|
1 |
|c 2016
|
| 336 |
|
|
|a Text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a ƒaComputermedien
|b c
|2 rdamedia
|
| 338 |
|
|
|a ƒa Online-Ressource
|b cr
|2 rdacarrier
|
| 500 |
|
|
|a Date Completed 28.06.2016
|
| 500 |
|
|
|a Date Revised 02.12.2018
|
| 500 |
|
|
|a published: Print-Electronic
|
| 500 |
|
|
|a Citation Status MEDLINE
|
| 520 |
|
|
|a Copyright © 2016 Elsevier Inc. All rights reserved.
|
| 520 |
|
|
|a The muscarinic type 3 receptor (M3R) plays a pivotal role in the pathogenesis of Sjögren's syndrome (SS). Characterization of the crosstalk between M3R and EGFR has been investigated in some human malignancies. In the current study, we sought to investigate whether EGFR mimic immunization could alleviate the abnormal immune responses in an experimental SS-like model triggered by M3R peptides. After immunization with the combination of mimotope and M3R peptide, the active immunization targeting EGFR induced by the mimotope could reduce the marked infiltration of mononuclear cells, the high titer of antibodies against M3R and the accumulation of crucial pro-inflammatory cytokines in mice immunized with M3R peptide. Mechanistic analysis showed that mimotope immunization could alleviate the autoimmune response through inhibiting mitochondrion-mediated anti-apoptosis and up-regulating the FAS apoptosis pathway. These results may help to clarify the role of M3R in the pathogenesis of SS and suggested that transactivation of the EGFR signaling pathway may help M3R activate the autoimmune response in the pathogenesis of SS
|
| 650 |
|
4 |
|a Journal Article
|
| 650 |
|
4 |
|a Research Support, Non-U.S. Gov't
|
| 650 |
|
4 |
|a Epidermal growth factor receptor
|
| 650 |
|
4 |
|a Mimotope
|
| 650 |
|
4 |
|a Muscarinic type 3 receptor
|
| 650 |
|
4 |
|a Sjögren's syndrome
|
| 650 |
|
7 |
|a Epitopes
|2 NLM
|
| 650 |
|
7 |
|a Peptide Fragments
|2 NLM
|
| 650 |
|
7 |
|a Receptor, Muscarinic M3
|2 NLM
|
| 650 |
|
7 |
|a EGFR protein, mouse
|2 NLM
|
| 650 |
|
7 |
|a EC 2.7.10.1
|2 NLM
|
| 650 |
|
7 |
|a ErbB Receptors
|2 NLM
|
| 650 |
|
7 |
|a EC 2.7.10.1
|2 NLM
|
| 700 |
1 |
|
|a Wang, Yongfu
|e verfasserin
|4 aut
|
| 700 |
1 |
|
|a Xing, Rui
|e verfasserin
|4 aut
|
| 700 |
1 |
|
|a Bai, Li
|e verfasserin
|4 aut
|
| 700 |
1 |
|
|a Li, Changhong
|e verfasserin
|4 aut
|
| 700 |
1 |
|
|a Li, Zhengqian
|e verfasserin
|4 aut
|
| 700 |
1 |
|
|a Liu, Xiangyuan
|e verfasserin
|4 aut
|
| 773 |
0 |
8 |
|i Enthalten in
|t Clinical immunology (Orlando, Fla.)
|d 1999
|g 163(2016) vom: 01. Feb., Seite 111-9
|w (DE-627)NLM098196855
|x 1521-7035
|7 nnns
|
| 773 |
1 |
8 |
|g volume:163
|g year:2016
|g day:01
|g month:02
|g pages:111-9
|
| 856 |
4 |
0 |
|u http://dx.doi.org/10.1016/j.clim.2016.01.006
|3 Volltext
|
| 912 |
|
|
|a GBV_USEFLAG_A
|
| 912 |
|
|
|a SYSFLAG_A
|
| 912 |
|
|
|a GBV_NLM
|
| 912 |
|
|
|a GBV_ILN_11
|
| 912 |
|
|
|a GBV_ILN_24
|
| 912 |
|
|
|a GBV_ILN_350
|
| 951 |
|
|
|a AR
|
| 952 |
|
|
|d 163
|j 2016
|b 01
|c 02
|h 111-9
|